Healthtech Startups

A company founded in June 2021 by a technology executive with a background in fintech and mobile platforms. The page provides an executive's career biography but does not describe the company's product or service.

2 investors

EXORPHIA develops extracellular vesicle (EV) technology for assisted reproductive medicine, focusing on cell-free IVF culture medium additives to improve embryo development and fertilization success rates. The company targets fertility clinics and academic institutions in reproductive medicine.

2 investors

HOKUTO is a clinical support app for physicians that provides evidence-based medical information, medical calculation tools, and knowledge management features to streamline clinical decision-making. The app targets physicians in Japan with access to drug information, clinical manuals, over 500 medical calculation tools, and document storage capabilities.

2 investors

iXgene develops regenerative medicine therapies using genome-edited induced pluripotent stem cells (iPSCs) to treat conditions including glioblastoma and traumatic brain injury. The company focuses on gene and cell therapies derived from genetically engineered stem cells.

2 investors

Luxonus develops photoacoustic (optical ultrasound) 3D imaging devices and services for visualizing blood and lymphatic vessels, building on technology from Japan's Cabinet Office ImPACT program. The company designs, manufactures, and sells medical imaging equipment based on photoacoustic technology, and is based in Japan.

2 investors

Smart119 develops ICT-based technology aimed at solving problems in medical and emergency care settings to help treat more patients. The company applies information and communications technology to deliver advanced medical care in Japan.

2 investors

SOXAI develops, manufactures, and sells wearable and IoT electronic devices and sensing technology for healthcare, along with related mobile/web applications and health-data analytics. The Japanese company applies non-invasive sensing technology to everyday products to support health monitoring and quality of life.

2 investors

xCARE operates a talent platform and project management service specialized for the medical industry, connecting external professional experts with pharmaceutical, medical device, and other medical product development projects. The Japan-based company aims to help startups and academic projects bring medical products to market by supplying needed specialists on a flexible basis.

2 investors

Xenoma develops e-skin, a washable garment-type IoT device embedded with stretchable sensors that measures healthcare data when worn. The company uses this technology for at-home medical testing services, including a 3-lead Holter electrocardiogram mailed for home use, aiming at preventive care for cardiovascular and other diseases.

2 investors

YStory develops AI-powered digital health solutions for women, with a focus on menopause management. The company offers JoyHer, a smartphone app that provides symptom tracking, expert articles, and community support for women navigating menopause in Japan.

2 investors

Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs. It works to create drug candidates and build product pipelines through collaboration with external institutions.

2 investors

Shaperon builds AI software to help companies in regulated industries handle complex, industry-specific compliance and legal requirements. Its compliance AI aims to speed up work and raise compliance standards for sectors where high-stakes, expert-driven judgment is required.

2 investors

Silvacompass develops software applications and provides business support services for the healthcare and senior care sectors, alongside big data collection and analysis capabilities.

2 investors

TWOCELLS (株式会社ツーセル) is a regenerative medicine venture developing therapies and products based on mesenchymal stem cells (MSCs), including its gMSC series for cartilage regeneration, along with serum-free culture media (STK series) and consulting services. Founded as a Hiroshima University spin-off, it also licenses its technology to pharmaceutical partners.

2 investors

Digireha (株式会社デジリハ) develops digital rehabilitation tools for people with disabilities, working under the mission of building a future not constrained by disability. The company frames disability through the "social model," treating the difficulties disabled people face as originating in society rather than the individual.

2 investors

Plusmedi Corp. develops patient-facing smartphone apps ("wellcne" and "MyHospital") and operates a personal health record (PHR) business. The company serves patients and healthcare providers in Japan.

2 investors

MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.

2 investors

Japanese healthcare startup (Mental Health Technologies, Inc.) that runs businesses in mental health solutions, medical workforce shift services, medical career support, and digital marketing, centered on connecting companies with physicians to address employees' physical and mental health. It serves corporate employers seeking to improve workforce well-being and occupational health.

2 investors

Rehasaku provides cloud-based rehabilitation and physical therapy management systems for medical institutions and treatment clinics in Japan. The platform includes exercise therapy management, guidance support tools, AI-powered posture analysis, appointment scheduling, and web marketing support.

2 investors

Ribomic is a company with a U.S. subsidiary engaged in research and development, including pharmaceutical and research-ethics-related activities. The page describes its compliance program, ethics committee, employee training, whistleblower hotline, and management of public research funding.

2 investors

A Japanese beauty technology company that develops cosmetic products using plasma technology. The company collaborates with national universities to create innovative skincare devices, including a home-use plasma facial device that delivers salon-quality treatments.

2 investors

Synyi (Shanghai Synyi Intelligent Information Technology), founded in 2016, develops AI, large language models, and big-data technologies for healthcare, offering more than 20 AI medical solutions covering clinical diagnosis and quality control, hospital operations management, and clinical research. It serves hospitals, medical alliances, healthcare companies, and health regulators, primarily in China, and is headquartered in Shanghai.

2 investors

Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices. Founded in 2004 and publicly listed (300347.SZ / 3347.HK), it provides services including clinical monitoring, regulatory affairs, data management, and site management.

2 investors

Predisease sells physician-recommended dietary supplement capsules and sachets through a mail-order system, with products targeting cholesterol, blood sugar, joint pain, menopause symptoms, and immunity. Orders are placed via a physician PPN reference and include automatic refills under a money-back efficacy guarantee.

1 investor